1 2 3 4

Douglas P. Landsittel, PhD

photo

Professor of Medicine, Biostatistics and Clinical and Translational Science

Director, Section on Biomarkers and Prediction Modeling

Office: Center for Research on Health Care (CRHC) Data Center
200 Meyran Avenue, Suite 300
Pittsburgh, PA 15213
 
Phone: 412-864-3019
Fax: 412-568-9672
E-mail: landsitteldp@upmc.edu

Education
BS in Applied Mathematics, University of Pittsburgh, 1992
PhD in Biostatistics, University of Pittsburgh, Graduate School of Public Health, 1997

Area of Specialization/Research Interest  
Causal inference methods
Prognostic and prediction models
Design and analysis of biomarker studies
Occupational and injury epidemiology
Statistical model of renal function and transplant outcomes
 

Profile
Doug Landsittel is the Director of the Biomarkers and Prediction Modeling Section, Director of Biostatistics for the Starzl Transplant Institute, and Track Director of Comparative Effectiveness Research for the Institute for Clinical Research Education. He is also a faculty member of the Comparative Effectiveness Research Center and the Center for Research on Health Care.

Dr. Landsittel is currently the Program Director (2014-2019) of the Enhancing National Capacity in PCOR through Training Program, which is an AHRQ funded R25 grant focused on building capacity and expertise at Minority Serving Institutions in patient-centered comparative effectiveness research. He is also the PI of a PCORI contract entitled 'Modeling strategies for observational CER: what works best when?', which seeks to develop a decision tool for identifying optimal causal inference approaches for a given scenario. Doug also directs (with Dr. Bae in Radiology) the Data Coordinating and Imaging Analysis Center of the Consortium for Radiological Imaging Studies in Polycystic Kidney Disease (CRISP). CRISP is a 15-year ongoing observational study that seeks to characterize the relationship between kidney volume and renal decline.

He has published over 90 peer-reviewed papers, is on the editorial board for Journal of Clinical Oncology, and serves as a member of the NIH study section on Kidney, Nutrition, Obesity and Diabetes (KNOD), as well as a frequent ad hoc reviewer for CDC/NIOSH, PCORI, and NCI.

Recent Grants
Title: Modeling Strategies for Observational CER - What Works Best When?
Role: PI
Amount:
Funding Agency: Patient-Centered Outcomes Research Institute
Start Year: 2014
End Year: 2017
Title: Expanding National Capacity in PCOR through Training (ENACT)
Website: http://www.icre.pitt.edu/ENACT/index.aspx
Role: PI
Amount:
Funding Agency: Agency for Healthcare Research and Quality
Start Year: 2014
End Year: 2019
Title: Mechanisms Linking Hot Flashes to Cardiovascular Risks
Role: Co-investigator
Amount:
Funding Agency: NIH
Start Year: 2011
End Year: 2016
Title: Clinical and Translational Science Award, Education Core
Role: Co-Investigator
Amount:
Funding Agency: NIH
Start Year: 2011
End Year: 2016
Title: Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease (CRISP III) Data Coordinating and Imaging Analysis Center
Role: PI (with Ty Bae)
Amount:
Funding Agency: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Start Year: 2011
End Year: 2016

For Pub Med search results, click here.
This Web site is maintained by the Center for Research on Health Care (CRHC) Data Center.
Contact the webmaster at dcweb@pitt.edu. All rights reserved.